Profilo
Heather Savelle currently works at TScan Therapeutics, Inc., as Vice President-Investor Relations from 2021.
Ms. Savelle also formerly worked at Targacept, Inc., as Senior Director-Investor & Public Relations from 2012 to 2013, Argot Partners LLC, as Senior Vice President & Managing Director from 2016 to 2021, Dynogen Pharmaceuticals, Inc., as Senior Manager-Corporate Communications from 2004 to 2008, and Macdougall Biomedical Communications, Inc., as Senior Vice President from 2013 to 2016.
Ms. Savelle received her undergraduate degree from the University of California, Santa Barbara.
Posizioni attive di Heather Savelle
| Società | Posizione | Inizio |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Contatto Relazioni con gli Investitori | 05/10/2021 |
Precedenti posizioni note di Heather Savelle
| Società | Posizione | Fine |
|---|---|---|
Argot Partners LLC
Argot Partners LLC Miscellaneous Commercial ServicesCommercial Services Operates as a strategic communications consultancy | Corporate Officer/Principal | 01/09/2021 |
Macdougall Biomedical Communications, Inc.
Macdougall Biomedical Communications, Inc. Marine ShippingTransportation Macdougall Biomedical Communications, Inc. is a private company based in Wellesley, MA. | Corporate Officer/Principal | 01/08/2016 |
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Discovers and develops nicotinic acetylcholine receptor based therapies | Public Communications Contact | 01/12/2013 |
Dynogen Pharmaceuticals, Inc.
Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Public Communications Contact | 01/07/2008 |
Formazione di Heather Savelle
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Dynogen Pharmaceuticals, Inc.
Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Discovers and develops nicotinic acetylcholine receptor based therapies | Health Technology |
University of California, Santa Barbara
University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Argot Partners LLC
Argot Partners LLC Miscellaneous Commercial ServicesCommercial Services Operates as a strategic communications consultancy | Commercial Services |
TScan Therapeutics, Inc.
TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
Macdougall Biomedical Communications, Inc.
Macdougall Biomedical Communications, Inc. Marine ShippingTransportation Macdougall Biomedical Communications, Inc. is a private company based in Wellesley, MA. | Transportation |
















